
Cancer rehabilitation program recent recipient of ACCC’s ‘Innovator Award’
“Physical therapists and occupational therapists typically don’t get a lot of cancer rehabilitation training in entry level programs, which is why Beaumont created a clinical cancer rehabilitation residency program,” said Dr. Christopher Wilson, residency program director, Beaumont, Troy.
The first accredited program of its kind in the U.S., Beaumont’s cancer rehabilitation residency is a 12-month program for licensed physical therapists.
“Cancer patients have unique needs –they have many doctor appointments, they have to position their bodies in certain ways for treatments; and chemotherapy can cause fatigue, weakness and difficulty moving around,” explained Wilson. “We developed a clinical residency program to specially train our therapists in all the unique care needs which occur as a result of cancer and its treatments – from a patient’s initial diagnosis through survivorship.”
In a collaborative learning environment, the residents learn how to assist cancer patients with:
“We train our therapists to understand radiation and chemotherapy,” Dr. Wilson said. “They also understand that they are an important part of an interdisciplinary team working to better serve patients – improving their quality of life and returning them to their everyday activities. Therapists participate in tumor boards and provide patient screenings at our multidisciplinary cancer clinics.”
Mary Alice Hewelt, a graduate of Beaumont’s first residency program, is paying it forward by serving as a residency program faculty member.
“I enjoy educating and sharing with others,” said Hewelt, a board-certified oncology physical therapist. “I want to mentor other clinicians seeking specialization as well as those currently in practice.”
Dr. Wilson and his team were recently named a recipient of the 2020 Association of Community Cancer Centers “Innovator Award.” The Beaumont Cancer Rehabilitation program was recognized for improving the patient experience; reducing hospital length of stay; and facilitating early identification of physical impairments, functional limitations, and/or treatment restrictions. Other key outcomes include reduction of cancer-related fatigue, lymphedema, falls and non-opioid pain management.